Allogeneic bone marrow transplantation for hematological malignancies--controversies and recent advances (Q41668011)

6 October 2017

1 reference

title

Allogeneic bone marrow transplantation for hematological malignancies--controversies and recent advances (English)

1 reference

6 October 2017

Ringdén O

1

1 reference

6 October 2017

1 January 1997

1 reference

6 October 2017

1 reference

6 October 2017

36

1 reference

6 October 2017

6

1 reference

6 October 2017

549-564

1 reference

Bone-marrow transplantation (first of two parts).

6 October 2017

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

The treatment of acute leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

HLA-identical sibling bone marrow transplantation in younger patients with chronic lymphocytic leukemia. European Group for Blood and Marrow Transplantation and the International Bone Marrow Transplant Registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 years

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

Selection of unrelated donors for bone marrow transplantation is improved by HLA class II genotyping with oligonucleotide hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

Acute graft versus host disease due to T lymphocytes recognizing a single HLA-DPB1*0501 mismatch.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

Incidence of chromosome abnormalities and clinical significance of karyotype in de novo acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

The clinical significance of karyotype in acute myelogenous leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

Quantitative acute leukemia cytogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

Autologous bone-marrow transplants compared with chemotherapy for children with acute lymphoblastic leukaemia in a second remission: a matched-pair analysis. The Berlin-Frankfurt-Münster Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

Donor search or autografting in patients with acute leukaemia who lack an HLA-identical sibling? A matched-pair analysis. Acute Leukaemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation (EBMT) and the Internation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

UK Medical Research Council randomised, multicentre trial of interferon-alpha n1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response. The UK Medical Research Council's Working Parties for Therapeutic Trials in Adult

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

Allogeneic bone marrow transplantation for secondary leukaemia and myelodysplastic syndrome: a survey by the Leukaemia Working Party of the European Bone Marrow Transplantation Group (EBMTG)

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

Bone marrow transplantation using unrelated donors for haematological malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

Solid cancers after bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

Marrow Transplantation for Acute Nonlymphocytic Leukemia after Treatment with Busulfan and Cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

G-CSF-mobilized peripheral blood progenitor cells for allogeneic transplantation: safety, kinetics of mobilization, and composition of the graft.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow Grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

Identical-twin bone marrow transplants for leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

The highest leukaemia-free survival after allogeneic bone marrow transplantation is seen in patients with grade I acute graft-versus-host disease. Acute and Chronic Leukaemia Working Parties of the European Group for Blood and Marrow Transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

Adoptive chemoimmunotherapy of cancer in animals: a review of results, principles, and problems

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

Surveillance tests for the diagnosis of invasive fungal infections in bone marrow transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

Treatment of hepatosplenic candidiasis with liposomal-amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

Allergic reactions and other rare side-effects of liposomal amphotericin.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

Safety and efficacy of liposomal amphotericin B in allogeneic bone marrow transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

Pharmacokinetics, safety and preliminary clinical experiences using foscarnet in the treatment of cytomegalovirus infections in bone marrow and renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

Prophylactic use of ganciclovir in allogeneic bone marrow transplantation: absence of clinical cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

Allogeneic bone marrow transplantation for 144 patients with severe aplastic anemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

Favourable outcome of patients older than 40 years of age after transplantation with marrow grafts depleted of lymphocytes by counterflow centrifugation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

Antitumor and antimetastatic activity of interleukin 12 against murine tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F02841869709001316

10.3109/02841869709001316

21 January 2018

Identifiers

DOI

1 reference

6 October 2017

1 reference

PubMed ID

9408144